Evidence map›Paper›PMID 39434115›Full record

ArticleBMC health services research2024

Provider and community perceptions of integrated COVID-19 and routine childhood immunisation programmes in Nigeria: a qualitative exploratory study.

Ayobami A Bakare, Kofoworola O Akinsola, Carina King, Abiodun A Sogbesan, Oluwabunmi R Bakare, Opeyemi Y Fadahunsi, Julius Salako, Adegoke G Falade, Sibylle Herzig van Wees

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ayobami A BakareDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden. bakare.ayobami.adebayo@ki.se.
Kofoworola O AkinsolaDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Carina KingDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Abiodun A SogbesanDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Oluwabunmi R BakareDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Opeyemi Y FadahunsiDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Julius SalakoDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Adegoke G FaladeDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Sibylle Herzig van Wees *Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Funding

Swedish Research Council 2020-04737
6 · The paper itself

Abstract

backgroundIn Nigeria, COVID-19 vaccines were delivered through outreach activities, as well as integrated within routine immunisation. However, evaluations of integrated approaches for novel vaccines are scarce. We aimed to understand the perceived benefits and challenges of integrating the COVID-19 vaccine within routine immunisation in Nigeria, and identify ways to strengthen this approach.

methodsWe conducted 30 semi-structured interviews with community members and healthcare workers in primary healthcare facilities (PHCs) in Jigawa (n = 16) and Oyo (n = 14) states, Nigeria from 08 August to 13 September 2022. Participants were selected purposively from PHCs. We obtained information on participants' perception about routine immunisation, and perceived benefits and challenges associated with integrated COVID-19 vaccine delivery. Healthcare worker and community interviews were analysed separately following a thematic analysis approach.

resultsWe identified four themes that describe the community and healthcare workers' responses, perceived impact, and the health system adaptions to the challenges associated with the integrated vaccine delivery approach. Community members expressed concern that children might be given COVID-19 vaccines instead of routine immunisations, while others appreciated the integrated approach due to their trust in the efficacy of COVID-19 vaccines, government, and healthcare providers. Healthcare providers perceived the integrated approach as improving vaccination coverage and awareness but noted additional problems of increased workload, vaccine scarcity, and prolonged clinic visits. Insufficient resources were subsisting barriers to effective integration in both states, but the provider's gender was also a challenge in Jigawa state. Additionally, the use of incentives to generate demand had ambiguous effects in Jigawa state.

conclusionTaking an integrated approach to deliver COVID-19 vaccines was acceptable by healthcare providers but community members expressed concerns. Given existing vaccination programmes have persistent challenges, it is pertinent to address these barriers to enhance effectiveness of an integrated approach.

Indexed as

COVID-19COVID-19 VaccinesImmunization ProgramsQualitative ResearchAdultAttitude of Health PersonnelChildFemaleHealth PersonnelHumansInterviews as TopicMaleMiddle AgedNigeriaSARS-CoV-2COVID-19 VaccinesChildhood immunisationCOVID-19 pandemicEssential health servicesHealth systemsIntegrated vaccine deliveryNigeriaPreventive care

Identifiers

PMID39434115
PMCPMC11492757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.